Management of neonatal bacterial infections. Rx: continual alertness, specific treatment, and ampicillin with kanamycin until the culture reports are back.
D000667:Ampicillin / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D002701:Chloramphenicol / Q000009:adverse effects; D003428:Cross Infection / Q000517:prevention & control; D004927:Escherichia coli Infections; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000175:diagnosis / Q000188:drug therapy*; D007239:Infections / Q000175:diagnosis / Q000188:drug therapy*; D007612:Kanamycin / Q000008:administration & dosage; D007710:Klebsiella Infections; D008297:Male; D010406:Penicillins / Q000627:therapeutic use; D011552:Pseudomonas Infections; D013449:Sulfonamides / Q000009:adverse effects; D013752:Tetracycline / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D010406:Penicillins; D013449:Sulfonamides; D007612:Kanamycin; D002701:Chloramphenicol; D000667:Ampicillin; D013752:Tetracycline